Hyzaar

[Losartan/HCTZ]

Overdosage & Contraindications
CONTRAINDICATIONS

HYZAAR is contraindicated in patients who are hypersensitive to any component of this product. Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs.

OVERDOSAGE

Text Continues Below

---

Losartan Potassium

Significant lethality was observed in mice and rats after oral administration of 1000 mg/ kg and 2000 mg/ kg, respectively, about 44 and 170 times the maximum recommended human dose on a mg/ m 2 basis. Limited data are available in regard to overdosage in humans. The most likely manifestation of overdosage would be hypotension and tachycardia; bradycardia could occur from parasympathetic (vagal) stimulation. If symptomatic hypotension should occur, supportive treatment should be instituted. Neither losartan nor its active metabolite can be removed by hemodialysis.

Hydrochlorothiazide

The oral LD50 of hydrochlorothiazide is greater than 10 g/ kg in both mice and rats. The most common signs and symptoms observed are those caused by electrolyte depletion (hypokalemia, hypochloremia, hyponatremia) and dehydration resulting from excessive diuresis. If digitalis has also been administered, hypokalemia may accentuate cardiac arrhythmias. The degree to which hydrochlorothiazide is removed by hemodialysis has not been established.